Medical imaging expert and Alacrita Partner, Colin G Miller PhD, presented his poster titled "Standardization of imaging reads for eligibility assessment of patients — Component of a risk mitigation strategy in the Tanezumab Clinical program" at the Osteoarthritis Research Society International (OARSI) Annual Meeting in Las Vegas.
Colin is an experienced medical imaging consultant and specializes in optimizing the use of medical imaging to evaluate the safety and efficacy of novel pharmaceuticals.
